查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1563836

全球女性健康檢查市場

Women's Health Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 173 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年全球女性健康檢查市場規模將達439億美元

預計2023年全球女性健康檢查市場規模為297億美元，預計2030年將達439億美元，2023-2030年分析期間複合年成長率為5.7%。乳癌檢測應用是本報告分析的細分市場之一，預計複合年成長率為 7.3%，到分析期結束時將達到 113 億美元。分析期間，傳染病檢查應用領域的複合年成長率預計為4.7%。

美國市場預計79億美元，中國預計複合年成長率9.9%

預計 2023 年美國女性健康診斷市場規模將達 79 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到106億美元，2023-2030年分析期間複合年成長率為9.9%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.2% 和 5.8%。在歐洲，德國的複合年成長率預計為 2.8%。

全球女性健康診斷市場—主要趨勢與促進因素總結

為什麼女性健康檢查成為醫療保健領域的焦點？

由於人們對主要影響女性的疾病（如乳癌、子宮頸癌、骨質疏鬆症和生殖疾病）的早期發現、預防和管理的認知和關注不斷提高，女性用健康檢查成為醫療保健領域的焦點。這些診斷包括廣泛的測試和篩檢方法，用於監測和管理不同生命階段的女性健康，包括診斷影像、分子就地檢驗和基於實驗室的檢測。隨著個人化醫療、預防醫學和以患者為中心的方法日益受到重視，女性健康檢查對於改善世界各地女性的健康結果和生活品質變得至關重要。

哪些技術創新將徹底改變女性健康檢查？

分子診斷、診斷影像和就地檢驗的技術進步正在徹底改變女性的健康篩檢。次世代定序（NGS）、液態切片和伴同性診斷的發展使得更準確、非侵入性地檢測基因突變、癌症和其他健康狀況成為可能，從而導致更有針對性的治療和個人化治療計劃。 3D乳房X光攝影、超音波和磁振造影(MRI) 等影像技術的創新使乳房組織的可視化更加準確和詳細，從而增強了乳癌的早期檢測和診斷。此外，人工智慧主導的分析、數位病理學和遠端醫療的整合正在提高女性健康檢查的可及性、效率和準確性，使檢查更加方便患者且更具成本效益。

女性健康診斷市場面臨哪些挑戰與機會？

女性健康診斷市場由多種因素推動，包括先進診斷測試的高成本、低收入地區獲得優質醫療保健的機會有限，以及需要提高對面臨挑戰的女性健康問題的認知和教育。此外，診斷測試的監管和報銷環境複雜且耗時。然而，這些挑戰也帶來了巨大的成長和創新機會。癌症、心血管疾病和骨質疏鬆症等慢性病的盛行率不斷上升，推動了對早期檢測和預防性診斷的需求。個人化醫療、遠端醫療和家庭檢測的興起為診斷製造商創造了新的成長機會，這些製造商提供創新、方便且價格實惠的解決方案。此外，人們對婦女健康計劃、政府措施和公共衛生宣傳活動的興趣日益濃厚，對全面全面的婦女健康檢查的需求也隨之增加。

是什麼推動了女性健康檢查市場的成長？

女性健康診斷市場的成長是由女性慢性病和文明病的盛行率不斷上升、對早期檢測和個人化醫療的需求不斷增加以及分子​​診斷、診斷成像和人工智慧主導分析的技術進步所推動的。隨著醫療保健提供者和患者尋求改善女性的健康結果和生活品質，對提供早期檢測、非侵入性檢測和標靶治療的全面、準確的診斷解決方案的需求將極大地推動市場需求。次世代定序、數位病理學、人工智慧主導的診斷和遠端醫療等技術創新正在提高女性健康檢查的能力和可及性，使其對醫療保健專業人員和患者都更具吸引力。隨著相關人員尋求針對女性健康的先進、綜合診斷解決方案，預防性護理的擴展、遠端醫療和家庭檢測的成長以及對女性健康宣傳和意識提升的日益關注正在推動市場成長。

受訪企業範例（41家知名企業）

  • Alere, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Quest Diagnostics, Inc.
  • Siemens AG

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP15688

Global Women's Health Diagnostics Market to Reach US$43.9 Billion by 2030

The global market for Women's Health Diagnostics estimated at US$29.7 Billion in the year 2023, is expected to reach US$43.9 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Breast Cancer Testing Application, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$11.3 Billion by the end of the analysis period. Growth in the Infectious Disease Testing Application segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.9 Billion While China is Forecast to Grow at 9.9% CAGR

The Women's Health Diagnostics market in the U.S. is estimated at US$7.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$10.6 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Women’s Health Diagnostics Market - Key Trends & Drivers Summarized

Why Is Women’s Health Diagnostics Gaining Prominence in Healthcare?

Women’s health diagnostics is gaining prominence in healthcare due to the growing awareness and focus on early detection, prevention, and management of diseases that predominantly affect women, such as breast cancer, cervical cancer, osteoporosis, and reproductive health disorders. These diagnostics encompass a wide range of tests and screening methods, including imaging, molecular diagnostics, point-of-care testing, and lab-based assays, to monitor and manage women's health across different life stages. With the increasing emphasis on personalized medicine, preventive care, and patient-centric approaches, women’s health diagnostics are becoming essential for improving health outcomes and quality of life for women worldwide.

What Technological Innovations Are Transforming Women’s Health Diagnostics?

Technological advancements in molecular diagnostics, imaging, and point-of-care testing are significantly transforming women’s health diagnostics. The development of next-generation sequencing (NGS), liquid biopsy, and companion diagnostics is enabling more precise and non-invasive detection of genetic mutations, cancers, and other health conditions, leading to better-targeted therapies and personalized treatment plans. Innovations in imaging technologies, such as 3D mammography, ultrasound, and magnetic resonance imaging (MRI), are providing more accurate and detailed visualization of breast tissues, enhancing early detection and diagnosis of breast cancer. Additionally, the integration of AI-driven analytics, digital pathology, and telemedicine is improving the accessibility, efficiency, and accuracy of women’s health diagnostics, making them more patient-friendly and cost-effective.

What Are the Challenges and Opportunities in the Women’s Health Diagnostics Market?

The women’s health diagnostics market faces several challenges, including the high cost of advanced diagnostic tests, limited access to quality healthcare in low-income regions, and the need for increased awareness and education about women’s health issues. The regulatory and reimbursement landscape for diagnostic tests can also be complex and time-consuming. However, these challenges present significant opportunities for growth and innovation. The increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and osteoporosis, is driving the demand for early detection and preventive diagnostics. The rise of personalized medicine, telehealth, and home-based testing is creating new growth opportunities for diagnostic manufacturers to offer innovative, accessible, and affordable solutions. Moreover, the growing focus on women’s health advocacy, government initiatives, and public health campaigns is driving the need for comprehensive and integrated women’s health diagnostics.

What Is Driving the Growth of the Women’s Health Diagnostics Market?

The growth in the Women’s Health Diagnostics market is driven by several factors, including the increasing prevalence of chronic and lifestyle-related diseases among women, rising demand for early detection and personalized medicine, and technological advancements in molecular diagnostics, imaging, and AI-driven analytics. The need for comprehensive and accurate diagnostic solutions that offer early detection, non-invasive testing, and targeted therapies is significantly boosting market demand as healthcare providers and patients seek to improve health outcomes and quality of life for women. Technological innovations such as next-generation sequencing, digital pathology, AI-driven diagnostics, and telemedicine are enhancing the capabilities and accessibility of women’s health diagnostics, making them more attractive to both healthcare professionals and patients. The expansion of preventive care, the growth of telehealth and home-based testing, and the increasing focus on women’s health advocacy and awareness are also driving market growth as stakeholders seek advanced and integrated diagnostic solutions for women’s health.

Select Competitors (Total 41 Featured) -

  • Alere, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Quest Diagnostics, Inc.
  • Siemens AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Women's Health Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases and Growing Awareness for Early Detection in Women
    • Increasing Demand for Point-of-Care and Home-Based Diagnostic Solutions
    • Advancements in Molecular Diagnostics and Next-Generation Sequencing for Women's Health
    • Growing Focus on Personalized Medicine and Companion Diagnostics for Targeted Therapies
    • Impact of Digital Health and Telemedicine on Women's Health Diagnostics Accessibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Women's Health Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Women's Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Breast Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Breast Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Breast Cancer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Infectious Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cervical Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cervical Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Cervical Cancer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Osteoporosis Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Osteoporosis Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Osteoporosis Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Prenatal Genetic Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Prenatal Genetic Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Prenatal Genetic Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pregnancy & Fertility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pregnancy & Fertility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pregnancy & Fertility Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostic & Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diagnostic & Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Diagnostic & Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • JAPAN
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • CHINA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • EUROPE
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Women's Health Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • FRANCE
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • GERMANY
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Women's Health Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • INDIA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: India 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Women's Health Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Women's Health Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • AFRICA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030

IV. COMPETITION